Clinical trial Recruiting at 1 site Observational Ages 18 to 70

Investigating how sleep disorders affect lung cancer and immune response

Official title: Prospective Clinical Study Design: the Association of Sleep Disorders With Tumor Immune Microenvironment and Prognosis of Lung Cancer

Run by Shanghai Zhongshan Hospital · NCT06941948 · Data updated 2026-11-12

This study is trying to see how sleep problems like insomnia and sleep apnea affect the immune system and treatment outcomes in people who have just been diagnosed with lung cancer.

Quick facts

Study typeObservational
Ages18 Years to 70 Years
SexAll
Enrollment400 (estimated)
SponsorShanghai Zhongshan Hospital
Academic / other
Drugs / interventionschemotherapy, immunotherapy
Locations1 site (Shanghai)
StatusRecruiting
StartedMay 1, 2025
Main results expectedJanuary 1, 2027
Study endsJanuary 1, 2028
Registry record updatedApril 24, 2025
Trial IDNCT06941948 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are newly diagnosed stage III-IV non-small-cell lung cancer patients who are not receiving systemic therapy.

Probably not a fit

Patients with severe mental illness, other malignant tumors, or those receiving sleep medication may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational cohort study aims to explore the relationship between sleep disorders, such as insomnia and obstructive sleep apnea, and the tumor immune microenvironment in patients with lung cancer. It will involve newly diagnosed primary lung cancer patients who will be stratified based on their sleep disorder status, confirmed through polysomnography and validated questionnaires. The study will follow participants for three years to assess how these disorders impact immunotherapy responses and long-term clinical outcomes.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment strategies for lung cancer patients by addressing sleep disorders and their effects on immune response.

How similar studies have gone: While there is limited prospective research on this specific topic, related studies have shown that sleep disorders can influence immune responses in cancer patients.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with newly diagnosed stage III-IV non-small-cell lung cancer (NSCLC) not receiving systemic therapy (chemotherapy, immunotherapy, or radiotherapy)

Exclusion Criteria:

* Patients with severe mental illness, other malignant tumors, or receiving sleep medication

Where it's running

  • Zhong Shan hospital
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.